Unknown Speaker

Can we talk about Hillary Cass for a minute? I mean, she is obviously, undoubtedly, an extremely important figure in this space. I mean, her report. Why?

I mean, you're going to have to ask the NHS that. They asked her to conduct the review. I mean, she's had a long career in pediatrics, but not, obviously, with kids with gender dysphoria. Well, there you go.

I mean, you're going to have to ask the NHS that. They asked her to conduct the review. I mean, she's had a long career in pediatrics, but not, obviously, with kids with gender dysphoria. Well, there you go.

You know, why is she important? I mean, she's important because her recommendations have just been adopted by the NHS in England and Scotland and...

You know, why is she important? I mean, she's important because her recommendations have just been adopted by the NHS in England and Scotland and...

health experts in major health groups in the U.S., major health groups in the U.K., in Sweden, looking at the same data, the same scientific literature that does not respect geographic boundaries. We're looking at the same studies in this small field and reaching very different conclusions. And I think that's a really legitimate question to ask is why is that happening? Regardless of who...

health experts in major health groups in the U.S., major health groups in the U.K., in Sweden, looking at the same data, the same scientific literature that does not respect geographic boundaries. We're looking at the same studies in this small field and reaching very different conclusions. And I think that's a really legitimate question to ask is why is that happening? Regardless of who...

I mean, something you said is that we need to be listening to trans people on this. I mean, Dr. Cass kind of says that, too, and she did talk to young trans people before.

I mean, something you said is that we need to be listening to trans people on this. I mean, Dr. Cass kind of says that, too, and she did talk to young trans people before.

I understand that. Young adults and older trans people, like she says very clearly in her report and even clearer, I felt, in our interview that there are absolutely kids who benefit from these treatments. And the question that we need to be asking ourselves right now is do we have enough evidence to be able to tell accurately who those kids are?

I understand that. Young adults and older trans people, like she says very clearly in her report and even clearer, I felt, in our interview that there are absolutely kids who benefit from these treatments. And the question that we need to be asking ourselves right now is do we have enough evidence to be able to tell accurately who those kids are?

So you're saying like she's been satisfied in people being happy with the choice that they made.

So you're saying like she's been satisfied in people being happy with the choice that they made.

Mm-hmm.

Mm-hmm.

I mean, I sort of asked her about this too, Marci, this, you know, how to weigh clinical experience, what, you know, doctors like yourself see with their own eyes in the exam room versus the evidence, like when the evidence is not crystal clear. And she gave a pretty nuanced answer.

I mean, I sort of asked her about this too, Marci, this, you know, how to weigh clinical experience, what, you know, doctors like yourself see with their own eyes in the exam room versus the evidence, like when the evidence is not crystal clear. And she gave a pretty nuanced answer.

She said it absolutely does matter, but that she also heard from doctors in this space who have legitimate concerns, and there isn't clear clinical consensus in this space, that there are people who are worried about the new cohort that she's talking about and

She said it absolutely does matter, but that she also heard from doctors in this space who have legitimate concerns, and there isn't clear clinical consensus in this space, that there are people who are worried about the new cohort that she's talking about and

Even with the... teenagers that are the focus of her report?